BK0579 Biomedical
- 740.196
- -1.710-0.23%
Morgan Stanley Starts Pacific Shuanglin Bio-pharmacy at Overweight With 37 Yuan Price Target
Morgan Stanley Starts China Resources Boya Bio-pharmaceutical Group at Equal-weight; Price Target Is 37 Yuan
Nomura Adjusts Pharmaron's Price Target to 31.41 Yuan From 36.68 Yuan, Keeps at Buy
Nomura Adjusts Asymchem Laboratories' Price Target to 118.48 Yuan From 127.21 Yuan Keeps at Buy
Jefferies Adjusts Hangzhou First's Price Target to 32.68 Yuan From 35.54 Yuan, Keeps at Buy
Nomura Adjusts Jiangsu Hengrui Medicine's Price Target to 51.12 Yuan From 49.24 Yuan, Keeps at Neutral
Nomura Adjusts Asymchem Laboratories Tianjin's Price Target to HK$90.12 From HK$134.59, Keeps at Buy
Analysts Are Bullish on These Healthcare Stocks: Guangzhou Baiyunshan Pharmaceutical Holdings Company (GZPHF), Mesoblast Limited (MEOBF)
Jefferies Adjusts Qingdao Haier Biomedical's Price Target to 80 Yuan From 100 Yuan, Keeps at Buy
Nomura Adjusts Pharmaron's Price Target to 61.24 Yuan From 66.94 Yuan, Keeps at Buy
Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to HK$134.59 From HK$130.30, Keeps at Buy
Nomura Adjusts Jiangsu Hengrui Medicine's Price Target to 49.24 Yuan From 50.19 Yuan, Keeps at Neutral
Nomura Adjusts Pharmaron's Price Target to 66.94 Yuan From 73.38 Yuan, Keeps at Buy
Nomura Adjusts Asymchem Laboratories Tianjin's Price Target to 185.66 Yuan From 190.13 Yuan, Keeps at Buy
Nomura Adjusts Asymchem Laboratories Tianjin's Price Target to HK$132.67 From HK$131.85, Keeps at Buy
Nomura Adjusts Asymchem Laboratories Tianjin's Price Target to 188.96 Yuan From 187.62 Yuan, Keeps at Buy
Nomura Adjusts Jiangsu Hengrui Pharmaceuticals' Price Target to 34.13 Yuan From 31.71 Yuan, Keeps at Neutral